Physician profile
Anna Mosley
NPI 1376302711
$1,208.99
in general payments reported to CMS, 2019-2025
12 companies · $1,209 in 2025
The $1,209 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Travel and Lodging: $119 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.99 |
| Travel and Lodging | $119.00 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $356.77 | 2025 | Interstim |
| Sumitomo Pharma America, INC. | $287.88 | 2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $156.48 | 2025 | Provenge |
| Urogen Pharma, INC. | $125.87 | 2025 | |
| Janssen Biotech, INC. | $77.46 | 2025 | Erleada |
| Coloplast Corp | $67.90 | 2025 | |
| Immunitybio, INC. | $46.41 | 2025 | |
| Endo USA, INC. | $23.11 | 2025 | Aveed, Xiaflex |
| Progenics Pharmaceuticals, INC. | $18.44 | 2025 | |
| Tolmar, INC. | $18.12 | 2025 | Eligard, Jatenzo |
| Abbvie INC. | $16.14 | 2025 | |
| Provepharm INC. | $14.41 | 2025 | Bludigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Mosley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.